[Information] Proposal for JUNIOR/Big Kahuna
Productivity increased fivefold! Featuring the impact of introducing JUNIOR/Big Kahuna.
This document provides information about JUNIOR/Big Kahuna. It introduces various achievements in application automation, the impact of implementing JUNIOR/Big Kahuna, and examples of powder weighing automation configurations. [Contents (excerpt)] ■ Case studies of automation implementation using JUNIOR/Big Kahuna ■ Adoption of a modular system that allows for various workflow configurations ■ Analysis data is automatically integrated by LEA software ■ Examples of reaction screening automation configurations ■ Process control for various sample preparation *For more details, please refer to the PDF document or feel free to contact us.
basic information
【Other Publication Contents (Excerpt)】 ■Achievements in Application Automation <Organic Synthesis, Low Molecular Weight Compounds> - Pharmaceutical active ingredients, drug discovery - Automation of weighing multiple types of powders - Solubility (aqueous, organic, formulation vehicles) - Salts, polymorphs, co-crystals - Organic synthesis screening - Catalyst screening - Reaction optimization and kinetics profiling - Grinding tests, forced degradation tests - Content uniformity testing - Automation of sample preparation for ICP emission analysis - Solid dispersion screening - Micro-scale dissolution rate evaluation - Solubility testing for liquid formulation development - Characterization of powder flow *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Recommended products
Distributors
Raifiks Analytical Co., Ltd. conducts sales activities nationwide, primarily focusing on pharmaceutical companies. Therefore, we can propose products that align with the latest model information and trends. We offer suggestions for equipment suited to each department, from the drug discovery phase, where unique medications not available from other companies are developed, to production and manufacturing. Our network extends overseas, allowing us to propose products not available through Japanese distributors and to suggest the development of products that do not currently exist in the market. We will provide solutions tailored to our customers' needs.